What is the recommended colchicine (Colchicine) dosing regimen for chronic pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colchicine Dosing for Chronic Pericarditis

For chronic/recurrent pericarditis, use weight-adjusted colchicine dosing: 0.5 mg once daily if body weight <70 kg or 0.5 mg twice daily if ≥70 kg, continued for at least 6 months without a loading dose. 1

Dosing Regimen

Weight-Based Dosing

  • Patients <70 kg: 0.5 mg once daily 1, 2
  • Patients ≥70 kg: 0.5 mg twice daily 1, 2
  • No loading dose should be used for recurrent/chronic pericarditis (unlike acute pericarditis where loading may be considered) 1

Treatment Duration

  • Minimum duration: 6 months for recurrent pericarditis 1
  • Continue treatment until complete symptom resolution and inflammatory marker normalization 3
  • In the most difficult, resistant cases, gradual discontinuation may take several months 1

Combination Therapy

Colchicine should always be added on top of standard anti-inflammatory therapy (aspirin or NSAIDs), not used as monotherapy. 1

  • Aspirin: 500-1000 mg every 6-8 hours (range 1.5-4 g/day) 1
  • Ibuprofen: 600 mg every 8 hours (range 1200-2400 mg/day) 1
  • Taper NSAIDs by 250-500 mg (aspirin) or 200-400 mg (ibuprofen) every 1-2 weeks once symptoms resolve 1

Evidence for Efficacy

The CORP trial demonstrated robust efficacy in recurrent pericarditis, showing colchicine reduced recurrence rates from 55% to 24% at 18 months (absolute risk reduction 31%, NNT=3). 4, 5 This represents a 56% relative risk reduction. 5 Meta-analysis confirms colchicine approximately halves the recurrence rate in patients with recurrent pericarditis. 1, 6

Tapering Strategy

When discontinuing therapy after achieving complete response, taper one drug class at a time before gradually stopping colchicine. 1

  • First taper and discontinue NSAIDs/aspirin over weeks to months 1
  • Then gradually discontinue colchicine last, potentially over several months in resistant cases 1
  • Alternative final taper: 0.5 mg every other day for patients <70 kg 1

Critical Thresholds and Pitfalls

Corticosteroid Management

If corticosteroids are necessary (contraindication to NSAIDs, autoimmune disease, pregnancy), use low to moderate doses only (prednisone 0.2-0.5 mg/kg/day) as triple therapy with NSAIDs and colchicine. 1 Corticosteroids favor chronicity and more recurrences despite providing rapid symptom control. 1

Critical tapering threshold: When prednisone reaches 10-15 mg/day, use very slow decrements of only 1.0-2.5 mg at intervals of 2-6 weeks. 1 This is where most recurrences occur if tapering is too rapid.

Common Pitfalls to Avoid

  • Never use colchicine as monotherapy - it must be combined with NSAIDs/aspirin 1
  • Never stop treatment before 6 months minimum duration - inadequate treatment duration is a common cause of recurrence 1
  • Never increase corticosteroid doses or reinstate them if recurrence occurs - every effort should be made to manage recurrences with NSAIDs and colchicine alone 1
  • Never use loading doses for recurrent pericarditis (loading is only for acute first episodes) 1

Monitoring

  • Use CRP levels to guide treatment length and assess response 3, 2
  • Continue therapy until complete symptom resolution AND CRP normalization 2
  • Monitor for gastrointestinal side effects (abdominal pain, diarrhea), which are the most common adverse effects 4, 5

Safety Profile

Colchicine has similar rates of side effects (7%) and drug withdrawal (8% vs 5%) compared to placebo in recurrent pericarditis. 4 Gastrointestinal intolerance is the main side effect, but no severe adverse events occurred in major trials. 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pericarditis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colchicine Dosing for Post-Operative Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colchicine for pericarditis.

The Cochrane database of systematic reviews, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.